Biocon releases drug to treat breast cancer

India`s leading biotechnology firm Biocon Ltd. has released a new drug to treat metastatic breast cancer it developed jointly with US-based pharma major Mylan.

Biocon`s oral insulin to take few more years to hit market

Biocon may take a few more years to launch its oral insulin in the Indian market, said company`s Chairman and Managing Director Kiran Mazumdar Shaw here today.

Biocon chief seeks spl session to discuss crime against women

Biocon Limited chief and Bangalore Political Action Committee president Kiran Mazumdar Shaw today asked Chief Minister Siddaramaiah to convene a special session of the Legislature to discuss crime against women.

Biocon releases novel drug to treat skin disease

India`s leading biotech firm Biocon has unveiled a new drug to treat psoriasis, a skin disease that occurs when the immune system mistakes a normal skin cell for a pathogen.

Biocon launches biological drug to combat psoriasis

Bangalore-headquartered biotechnology company Biocon on Saturday announced the launch of a biological drug researched, developed and manufactured in the country to treat chronic plaque psoriasis and said it is in discussions to finalise a global partner to take it worldwide.

Biocon gets DCGI approval to market anti-psoriasis drug

Biotechnology major Biocon today said it has received approval from drug controller DCGI to market its product `Itolizumab`, used in the treatment of psoriasis.

Pfizer scraps insulin deal with India`s Biocon

Pfizer Inc, the world`s largest drugmaker, has scrapped a deal to sell insulin products made by Biocon Ltd.

Biocon`s Psoriasis molecule shows positive results

Biotechnology major Biocon today said its drug molecule `Itolizumab` has shown positive results in the Phase III trials.

Women tackle challenges better: Kiran M Shaw

Kiran Mazumdar Shaw, the ‘Queen of Biotech’ reveals how being a woman has actually helped her remain on top.

Women tackle challenges better: Kiran M Shaw

Kiran Mazumdar Shaw, the ‘Queen of Biotech’ reveals how being a woman has actually helped her remain on top.

Biocon Group registers Net Profit of Rs 81 cr

Biocon Group, including its German subsidiary Axicorp, for 3 months ended Dec 31, 2009, registered a Net Profit of Rs 81cr, a year-on-year growth of 187%.